Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
American Journal of Clinical Pathology|November 1, 1975
Pre-instrumental variables in coagulation testingJ A Koepke, J L Rodgers, M J OllivierJournal of Neurophysiology|December 1, 1993
Statistical analysis of neural organizationR P Erickson, J L Rodgers, W S SarleChild Development|February 1, 1992
Sibling delinquency and the family environment: shared and unshared influencesD C Rowe, J L Rodgers, S Meseck-BusheyClinical Chemistry|May 1, 1976
The anion gap: its use in quality controlD L Witte, J L Rodgers, D A BarrettApplied and Environmental Microbiology|December 3, 1999
cis-chlorobenzene dihydrodiol dehydrogenase (TcbB) from Pseudomonas sp. strain P51, expressed in Escherichia coli DH5alpha(pTCB149), catalyzes enantioselective dehydrogenase reactionsH Raschke, T Fleischmann, J R Van Der Meer, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 1999
Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertensionR A Ariëns, H P Kohler, M W Mansfield, et al.Thrombosis and Haemostasis|April 1, 1995
The suppression of the coagulation of nonanticoagulated whole blood in vitro by human umbilical endothelial cells cultivated on microcarriers is not dependent on protein C activationH P Kohler, M Müller, T Bombeli, et al.Thrombosis and Haemostasis|February 12, 1998
Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery diseaseH P Kohler, A M Carter, M H Stickland, et al.The Journal of Laboratory and Clinical Medicine|September 1, 1994
Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitroB Biedermann, A Rosenmund, M Muller, et al.Biotechnology and Bioengineering|February 10, 1999
An integrated process for the production of toxic catechols from toxic phenols based on a designer biocatalystM Held, A Schmid, H P Kohler, et al.Pageof 8